Professor Rafal Dziadziuszko completed his training in Radiotherapy (2001) and Medical Oncology (2004) at the Department of Oncology and Radiotherapy of the Medical University of Gdańsk, Poland.

He subsequently completed a translational cancer research fellowship at the University of Colorado Cancer Center. Between 2005 and 2007 he worked on predictive assays for EGFR targeted therapies in lung cancer, including immunohistochemistry, gene copy number, and activating mutations.

His fellowship was funded by the International Union Against Cancer and the International Association for the Study of Lung Cancer. He then returned to his home institution to serve as a deputy chair of the department, and medical coordinator of Early Clinical Trials Unit.

Prof. Dziadziuszko’s main interests include lung cancer translational and clinical research, and he is a co-author of over 170 peer-reviewed articles and book chapters on this topic, including the Lung Cancer chapter in a recent edition of the Oxford Textbook of Oncology.

He is a member of the European Society for Medical Oncology, International Association for the Study of Lung Cancer, European Organisation for Research and Treatment of Cancer – Lung Cancer Group, European Society for Radiotherapy and Oncology, Polish Society of Oncology and Polish Society of Radiation Oncology. He has also participated in the organisation of several academic clinical research studies in Poland and Central Europe and serves as the Vice-Chairman of the Central and East European Oncology Group, and member of the Scientific Committee of the European Thoracic Oncology Platform.

His current work includes identification of novel molecular targets for early lung cancer trials, evaluation of novel radiotherapy strategies in thoracic malignancies and research on lung cancer screening programs. He has been involved in EGFR, IGF-1R, HER2, ALK, ROS1, MET and immune checkpoint translational and clinical research. He is a mentor of six past and ongoing PhD students.

In 2017, Prof. Dziadziuszko was honoured with the Heine H. Hansen lifetime contribution to lung cancer research and education award.

He currently serves as the Faculty Coordinator for the ESMO Non-Metastatic NSCLC and other Thoracic Malignancies Faculty Group.